(Q37775558)

23 August 2017

1 reference

title

NADPH oxidases and cardiac remodelling (English)

1 reference

23 August 2017

Adam Nabeebaccus

1

1 reference

23 August 2017

Min Zhang

series ordinal

2

1 reference

23 August 2017

Ajay M Shah

series ordinal

3

1 reference

23 August 2017

publication date

1 January 2011

1 reference

23 August 2017

published in

Heart Failure Reviews

1 reference

23 August 2017

volume

16

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

5-12

1 reference

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Controversies in ventricular remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Role of oxidative stress in cardiac hypertrophy and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Oxidative stress and left ventricular remodelling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Free radicals in the physiological control of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Increased myocardial NADPH oxidase activity in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

NADPH oxidases in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

The neutrophil NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

NOX enzymes and the biology of reactive oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Molecular composition and regulation of the Nox family NAD(P)H oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Regulation of Nox and Duox enzymatic activity and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Nox proteins in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Regulation of NADPH oxidases: the role of Rac proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Redox sensitive signaling pathways in cardiac remodeling, hypertrophy and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Activation of NADPH oxidase during progression of cardiac hypertrophy to failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Requirement of Rac1 in the development of cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Critical role of apoptosis signal-regulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Rac1 mediates sex difference in cardiac tumor necrosis factor-alpha expression via NADPH oxidase-ERK1/2/p38 MAPK pathway in endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Redox regulation of cardiac calcium channels and transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Rac1 is required for cardiomyocyte apoptosis during hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Oxidative stress and cardiac repair/remodeling following infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Overexpression of TGFbeta1 by adeno-associated virus type-2 vector protects myocardium from ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9186-2

Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction

21 January 2018

1 reference

12 December 2020

Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling

1 reference

12 December 2020

Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor

1 reference

12 December 2020

The role of statins in chronic heart failure

1 reference

12 December 2020

Oxygen, oxidative stress, hypoxia, and heart failure

1 reference

12 December 2020

10.1007/S10741-010-9186-2

Identifiers

DOI

1 reference

23 August 2017

1 reference